Feedback

Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration

Affiliation
Department of Anesthesiology ,Hunan Cancer Hospital ,The Affiliated Cancer Hospital of Xiangya School of Medicine ,Central South University ,Changsha ,China
Gan, Li;
Affiliation
Department of Nuclear Medicine ,Hunan Cancer Hospital ,The Affiliated Cancer Hospital of Xiangya School of Medicine ,Central South University ,Changsha ,China
Xiao, Qiyu;
Affiliation
Department of Pharmacy ,The Third Xiangya Hospital ,Central South University ,Changsha ,China
Zhou, Yusong;
Affiliation
Department of Nuclear Medicine ,Hunan Cancer Hospital ,The Affiliated Cancer Hospital of Xiangya School of Medicine ,Central South University ,Changsha ,China
Fu, Ying;
Affiliation
Department of Pathology ,Hunan Cancer Hospital ,The Affiliated Cancer Hospital of Xiangya School of Medicine ,Central South University ,Changsha ,China
Tang, Mengjie

Background: Kidney renal papillary cell carcinoma (KIRP) is a rare malignancy with a very poor prognosis. Anoikis is a specific form of apoptosis involved in carcinogenesis, but the role of anoikis in KIRP has not been explored. Methods: Anoikis-related genes (ARGs) were obtained from the GeneCards database and Harmonizome database and were used to identify different subtypes of KIRP and construct a prognostic model of KIRP. In addition, we also explored the immune microenvironment and enrichment pathways among different subtypes by consensus clustering into different subtypes. Drug sensitivity analysis was used to screen for potential drugs. Finally, we verified the mRNA and protein expression of the independent prognostic gene PLK1 in patient tissues and various cells and further verified the changes in relevant prognostic functions after constructing a PLK1 stable knockdown model using ShRNA. Results: We identified 99 differentially expressed anoikis-related genes (DEGs) associated with KIRP survival, and selected 3 genes from them to construct a prognostic model, which can well predict the prognosis of KIRP patients. Consensus clustering divided KIRP into two subtypes, and there was a significant difference in survival rates between the two subtypes. Immune profiling revealed differing immune statuses between the two subtypes, and functional analysis reveals the differential activity of different functions in different subtypes. Drug sensitivity analysis screened out 15 highly sensitive drugs in the high-risk group and 11 highly sensitive drugs in the low-risk group. Univariate and multivariate Cox regression analysis confirmed that PLK1 was an independent prognostic factor in KIRP, and its mRNA and protein expression levels were consistent with gene differential expression levels, both of which were highly expressed in KIRP. Functional verification of PLK1 in KIRP revealed significant results. Specifically, silencing PLK1 inhibited cell proliferation, clonogenicity, and migration, which indicated that PLK1 plays an important role in the proliferation and migration of KIRP. Conclusion: The prognosis model constructed by ARGs in this study can accurately predict the prognosis of KIRP patients. ARGs, especially PLK1, play an important role in the development of KIRP. This research can help doctors provide individualized treatment plans for KIRP patients and provide researchers with new research ideas.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2023 Gan, Xiao, Zhou, Fu and Tang.

Use and reproduction: